http://bio2rdf.org/drugbank_resource:DB00361_DB00951_nanopub.RA0JLG8XNNjeBO2TPXJGAolrAgF-AVV2TAZf5dyTZeqjk#head http://bio2rdf.org/drugbank_resource:DB00361_DB00951_nanopub.RA0JLG8XNNjeBO2TPXJGAolrAgF-AVV2TAZf5dyTZeqjk http://www.nanopub.org/nschema#hasAssertion http://bio2rdf.org/drugbank_resource:DB00361_DB00951_nanopub.RA0JLG8XNNjeBO2TPXJGAolrAgF-AVV2TAZf5dyTZeqjk#assertion http://bio2rdf.org/drugbank_resource:DB00361_DB00951_nanopub.RA0JLG8XNNjeBO2TPXJGAolrAgF-AVV2TAZf5dyTZeqjk http://www.nanopub.org/nschema#hasProvenance http://bio2rdf.org/drugbank_resource:DB00361_DB00951_nanopub.RA0JLG8XNNjeBO2TPXJGAolrAgF-AVV2TAZf5dyTZeqjk#provenance http://bio2rdf.org/drugbank_resource:DB00361_DB00951_nanopub.RA0JLG8XNNjeBO2TPXJGAolrAgF-AVV2TAZf5dyTZeqjk http://www.nanopub.org/nschema#hasPublicationInfo http://bio2rdf.org/drugbank_resource:DB00361_DB00951_nanopub.RA0JLG8XNNjeBO2TPXJGAolrAgF-AVV2TAZf5dyTZeqjk#publicationInfo http://bio2rdf.org/drugbank_resource:DB00361_DB00951_nanopub.RA0JLG8XNNjeBO2TPXJGAolrAgF-AVV2TAZf5dyTZeqjk http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://bio2rdf.org/drugbank_resource:DB00361_DB00951_nanopub.RA0JLG8XNNjeBO2TPXJGAolrAgF-AVV2TAZf5dyTZeqjk#assertion http://bio2rdf.org/drugbank:DB00361 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00361_DB00951 http://bio2rdf.org/drugbank:DB00951 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00361_DB00951 http://bio2rdf.org/drugbank_resource:DB00361_DB00951 http://purl.org/dc/terms/identifier drugbank_resource:DB00361_DB00951 http://bio2rdf.org/drugbank_resource:DB00361_DB00951 http://purl.org/dc/terms/title DDI between Vinorelbine and Isoniazid - Isoniazid, a strong CYP3A4 inhibitor, may increase the serum concentration of Vinorelbine by decreasing its metabolism. Consider alternate therapy to avoid Vinorelbine toxicity. Monitor for changes in the therapeutic and adverse effects of Vinorelbine if Isoniazid is initiated, discontinued or dose changed. http://bio2rdf.org/drugbank_resource:DB00361_DB00951 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction http://bio2rdf.org/drugbank_resource:DB00361_DB00951 http://www.w3.org/2000/01/rdf-schema#label DDI between Vinorelbine and Isoniazid - Isoniazid, a strong CYP3A4 inhibitor, may increase the serum concentration of Vinorelbine by decreasing its metabolism. Consider alternate therapy to avoid Vinorelbine toxicity. Monitor for changes in the therapeutic and adverse effects of Vinorelbine if Isoniazid is initiated, discontinued or dose changed. [drugbank_resource:DB00361_DB00951] http://bio2rdf.org/drugbank_resource:DB00361_DB00951_nanopub.RA0JLG8XNNjeBO2TPXJGAolrAgF-AVV2TAZf5dyTZeqjk#provenance http://bio2rdf.org/drugbank_resource:DB00361_DB00951_nanopub.RA0JLG8XNNjeBO2TPXJGAolrAgF-AVV2TAZf5dyTZeqjk#assertion http://semanticscience.org/resource/SIO_000253 http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3 http://bio2rdf.org/drugbank_resource:DB00361_DB00951_nanopub.RA0JLG8XNNjeBO2TPXJGAolrAgF-AVV2TAZf5dyTZeqjk#publicationInfo http://bio2rdf.org/drugbank_resource:DB00361_DB00951_nanopub.RA0JLG8XNNjeBO2TPXJGAolrAgF-AVV2TAZf5dyTZeqjk#signature.MC0CFFBbSlWPhZzC http://purl.org/nanopub/x/hasPublicKey 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 http://bio2rdf.org/drugbank_resource:DB00361_DB00951_nanopub.RA0JLG8XNNjeBO2TPXJGAolrAgF-AVV2TAZf5dyTZeqjk#signature.MC0CFFBbSlWPhZzC http://purl.org/nanopub/x/hasSignature MC0CFFBbSlWPhZzCYjABmDg7EUdMTkrmAhUAlmLknkZAtOMLnBv0ow8xm61L4gU= http://bio2rdf.org/drugbank_resource:DB00361_DB00951_nanopub.RA0JLG8XNNjeBO2TPXJGAolrAgF-AVV2TAZf5dyTZeqjk#signature.MC0CFFBbSlWPhZzC http://purl.org/nanopub/x/signedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://bio2rdf.org/drugbank_resource:DB00361_DB00951_nanopub.RA0JLG8XNNjeBO2TPXJGAolrAgF-AVV2TAZf5dyTZeqjk http://purl.org/dc/terms/created 2018-03-30T11:12:27.411+02:00 http://bio2rdf.org/drugbank_resource:DB00361_DB00951_nanopub.RA0JLG8XNNjeBO2TPXJGAolrAgF-AVV2TAZf5dyTZeqjk http://purl.org/dc/terms/license https://creativecommons.org/licenses/by-nc/4.0/ http://bio2rdf.org/drugbank_resource:DB00361_DB00951_nanopub.RA0JLG8XNNjeBO2TPXJGAolrAgF-AVV2TAZf5dyTZeqjk http://purl.org/nanopub/x/hasSignatureElement http://bio2rdf.org/drugbank_resource:DB00361_DB00951_nanopub.RA0JLG8XNNjeBO2TPXJGAolrAgF-AVV2TAZf5dyTZeqjk#signature.MC0CFFBbSlWPhZzC http://bio2rdf.org/drugbank_resource:DB00361_DB00951_nanopub.RA0JLG8XNNjeBO2TPXJGAolrAgF-AVV2TAZf5dyTZeqjk http://www.w3.org/ns/prov#wasGeneratedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#specializationOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://purl.org/dc/terms/identifier 3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#used https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasAssociatedWith https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasStartedBy http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/dc/terms/isVersionOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/pav/version eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234